South African paediatric nephrology perspective on eculizumab therapy for atypical HUS: A global review panel model for aHUS drug access

Dr Errol Gottlich  and  Professor Mignon McCulloch  Resilience, fortitude and determination. These characteristics describe the South African doctor treating patients within a complex and changing health system. Atypical HUS, with…

Continue Reading South African paediatric nephrology perspective on eculizumab therapy for atypical HUS: A global review panel model for aHUS drug access

Atypical HUS – Index of KEY RESOURCES

Jump to Section: About aHUS | Special Events | Clinical Information | Networks and Support | Patient Materials & Resources |aHUS Global Advocate:  NEWSLETTER |aHUS alliance Global Action | aHUS…

Continue Reading Atypical HUS – Index of KEY RESOURCES

Before aHUS endeavours fade

There have been moments and events in the past where someone whose endeavours make a significant difference for those who have been diagnosed with aHUS today. This is about one.…

Continue Reading Before aHUS endeavours fade

Atypical HUS – Index of KEY RESOURCES

Jump to Section: About aHUS | Special Events | Clinical Information | Networks and Support | Patient Materials (to Print & Share) |aHUS Global Advocate:  NEWSLETTER |aHUS alliance Global Action…

Continue Reading Atypical HUS – Index of KEY RESOURCES

The light and dark world of aHUS

Article No. 453 25 August 2021 Recently Astra Zeneca concluded its purchase of the  rare disease business unit, Alexion. $39 billion dollars was paid. Those stakeholders who risked their investment…

Continue Reading The light and dark world of aHUS